These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38332959)

  • 1. Pharmacologic Management of Sialorrhea in Neonatal and Pediatric Patients.
    Bradford CV; Parman AM; Johnson PN; Miller JL
    J Pediatr Pharmacol Ther; 2024; 29(1):6-21. PubMed ID: 38332959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycopyrrolate for chronic drooling in children.
    Eiland LS
    Clin Ther; 2012 Apr; 34(4):735-42. PubMed ID: 22445330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment options for drug-induced sialorrhea: Prescribing guidelines].
    Cuvelier E; Gressier B; Fovet T; Simon N; Décaudin B; Amad A
    Encephale; 2022 Dec; 48(6):700-711. PubMed ID: 35989107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of glycopyrrolate and other anticholinergic medications for sialorrhea in children with cerebral palsy.
    Bachrach SJ; Walter RS; Trzcinski K
    Clin Pediatr (Phila); 1998 Aug; 37(8):485-90. PubMed ID: 9729704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticholinergic treatment for sialorrhea in children: A systematic review.
    You P; Strychowsky J; Gandhi K; Chen BA
    Paediatr Child Health; 2022 May; 27(2):82-87. PubMed ID: 35599670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticholinergic medications for reducing drooling in children with developmental disability.
    Reid SM; Westbury C; Guzys AT; Reddihough DS
    Dev Med Child Neurol; 2020 Mar; 62(3):346-353. PubMed ID: 31495925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycopyrrolate oral solution: for chronic, severe drooling in pediatric patients with neurologic conditions.
    Garnock-Jones KP
    Paediatr Drugs; 2012 Aug; 14(4):263-9. PubMed ID: 22646067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sialorrhea: a management challenge.
    Hockstein NG; Samadi DS; Gendron K; Handler SD
    Am Fam Physician; 2004 Jun; 69(11):2628-34. PubMed ID: 15202698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialorrhea - therapeutic drug options.
    Tscheng DZ
    Ann Pharmacother; 2002 Nov; 36(11):1785-90. PubMed ID: 12398577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of glycopyrrolate oral solution for management of pathologic drooling in pediatric patients with cerebral palsy and other neurologic conditions.
    Zeller RS; Davidson J; Lee HM; Cavanaugh PF
    Ther Clin Risk Manag; 2012; 8():25-32. PubMed ID: 22298951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Nebulized Glycopyrrolate on Posterior Drooling in Patients with Brain Injury: Two Cases of Different Brain Lesions.
    Lee ZI; Yu KJ; Lee DH; Hong SK; Woo SB; Kim JM; Park D
    Am J Phys Med Rehabil; 2017 Aug; 96(8):e155-e158. PubMed ID: 28081026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of sialorrhea with glycopyrrolate: A double-blind, dose-ranging study.
    Mier RJ; Bachrach SJ; Lakin RC; Barker T; Childs J; Moran M
    Arch Pediatr Adolesc Med; 2000 Dec; 154(12):1214-8. PubMed ID: 11115305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycopyrrolate for treatment of clozapine-induced sialorrhea in adults.
    Blissit KT; Tillery E; Latham C; Pacheco-Perez J
    Am J Health Syst Pharm; 2014 Aug; 71(15):1282-7. PubMed ID: 25027535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of scopolamine transdermal patch in children with sialorrhea in a pediatric tertiary care hospital.
    Al Jeraisy M; AlFuraih M; AlSaif R; AlKhalifah B; AlOtaibi H; Abolfotouh MA
    BMC Pediatr; 2020 Sep; 20(1):437. PubMed ID: 32943036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of options for treating sialorrhea in amyotrophic lateral sclerosis.
    Banfi P; Ticozzi N; Lax A; Guidugli GA; Nicolini A; Silani V
    Respir Care; 2015 Mar; 60(3):446-54. PubMed ID: 25228780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycopyrrolate for drooling in children with medical complexity under three years of age.
    Lovardi E; De Ioris MA; Lettori D; Geremia C; Staccioli S; Bella GD; Scrocca R; Scarselli A; Aversa M; De Peppo F; Campana A; Castelli E
    Ital J Pediatr; 2022 Jan; 48(1):2. PubMed ID: 34998418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examining the Role of Sublingual Atropine for the Treatment of Sialorrhea in Patients with Neurodevelopmental Disabilities: A Retrospective Review.
    Petkus KD; Noritz G; Glader L
    J Clin Med; 2023 Aug; 12(16):. PubMed ID: 37629280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of sublingual atropine sulfate on clozapine-induced hypersalivation: a multicentre, randomised placebo-controlled trial.
    Mubaslat O; Lambert T
    Psychopharmacology (Berl); 2020 Oct; 237(10):2905-2915. PubMed ID: 32876732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycopyrrolate for treatment of clozapine-induced sialorrhea in three adolescents.
    Robb AS; Lee RH; Cooper EB; Siedel JV; Nusrat N
    J Child Adolesc Psychopharmacol; 2008 Feb; 18(1):99-107. PubMed ID: 18294092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.